glp 1 and blood pressure effects of SGLT2 inhibitors GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data - Belančić - British Journal of Clinical Pharmacology Hypertension: GLP-1s Like Ozempic, Wegovy
Description
In cardiovascular disease , studies have found these medications provide cardiovascular protection, with a 1420% reduction in major adverse cardiovascular events (MACE), a benefit understood to be at least partially mediated by anti-inflammatory pathways rather than glycemic control alone
The states with the highest obesity rates are Mississippi and West Virginia, where more than 40% of people are considered obese
Key Takeaways The question our licensed nurse injectors hear most from patients starting a GLP-1 program is some version of the same thing: does it matter where I inject? The answer is that the site you choose matters less than what you do with it over time
Gastrointestinal side effects represent another potential contributor to fatigue
Because semaglutide is a peptide, it is highly susceptible to enzymatic degradation in the gastrointestinal tract
